Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Durie

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
American Journal of Human Genetics|June 1, 1989
DNA marker haplotype association with pancreatic sufficiency in cystic fibrosisB S Kerem, J A Buchanan, P Durie, et al.
Clinical Genetics|January 12, 2010
Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?R Dorfman, T Nalpathamkalam, C Taylor, et al.
Pediatric Research|August 1, 1996
Phenotypic abnormalities in long-term surviving cystic fibrosis miceG Kent, M Oliver, J K Foskett, et al.
American Journal of Human Genetics|August 1, 1992
Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileusA Hamosh, T M King, B J Rosenstein, et al.
Nature Genetics|March 1, 1996
Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factorR Rozmahel, M Wilschanski, A Matin, et al.
Fertility and Sterility|October 31, 1998
Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutationsK Jarvi, S McCallum, J Zielenski, et al.
The Journal of Pediatrics|February 1, 1994
Pancreatitis in patients with organic acidemiasS G Kahler, W G Sherwood, D Woolf, et al.
Human Gene Therapy|April 3, 1998
Assessment of the efficacy of in vivo CFTR protein replacement therapy in CF miceM Ramjeesingh, L J Huan, M Wilschanski, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 21, 2014
Simultaneous liver-pancreas transplantation for cystic fibrosis-related liver disease: a multicenter experienceR H J Bandsma, M A Bozic, J A Fridell, et al.
Clinical Genetics|August 5, 2010
Understanding the population structure of North American patients with cystic fibrosisW Li, L Sun, M Corey, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
American Journal of Human Genetics|June 1, 1989
DNA marker haplotype association with pancreatic sufficiency in cystic fibrosisB S Kerem, J A Buchanan, P Durie, et al.
Clinical Genetics|January 12, 2010
Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?R Dorfman, T Nalpathamkalam, C Taylor, et al.
Pediatric Research|August 1, 1996
Phenotypic abnormalities in long-term surviving cystic fibrosis miceG Kent, M Oliver, J K Foskett, et al.
American Journal of Human Genetics|August 1, 1992
Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileusA Hamosh, T M King, B J Rosenstein, et al.
Nature Genetics|March 1, 1996
Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factorR Rozmahel, M Wilschanski, A Matin, et al.
Fertility and Sterility|October 31, 1998
Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutationsK Jarvi, S McCallum, J Zielenski, et al.
The Journal of Pediatrics|February 1, 1994
Pancreatitis in patients with organic acidemiasS G Kahler, W G Sherwood, D Woolf, et al.
Human Gene Therapy|April 3, 1998
Assessment of the efficacy of in vivo CFTR protein replacement therapy in CF miceM Ramjeesingh, L J Huan, M Wilschanski, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 21, 2014
Simultaneous liver-pancreas transplantation for cystic fibrosis-related liver disease: a multicenter experienceR H J Bandsma, M A Bozic, J A Fridell, et al.
Clinical Genetics|August 5, 2010
Understanding the population structure of North American patients with cystic fibrosisW Li, L Sun, M Corey, et al.
Pageof 6